DURHAM, N.C.--(

DURHAM, N.C.--(

BUSINESS WIRE

商业热线

)--MED-EL USA announced today that the U.S. Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants. SONNET 3 is the company’s lightest and smallest behind-the-ear audio processor and features integrated wireless direct streaming capabilities.

)--MED-EL USA今天宣布，美国食品和药物管理局批准了用于MED-EL人工耳蜗的新型SONNET 3音频处理器。SONNET 3是该公司最轻、最小的耳后音频处理器，具有集成的无线直接流媒体功能。

Superior hearing performance has always been at the forefront of MED-EL hearing implants. SONNET 3’s ASM 3.0 technology automatically adjusts the processor’s settings to match the environment. This includes reducing distracting background noises and leveraging dual microphones to allow users to focus on conversations..

优越的听力性能一直是MED-EL听力植入物的前沿。SONNET 3的ASM 3.0技术会自动调整处理器的设置以匹配环境。这包括减少分散注意力的背景噪音，利用双麦克风让用户专注于对话。。

The device supports binaural streaming, where bilateral users can pair two SONNET 3 processors or a SONNET 3 and another audio processor with AudioStream to enjoy their best hearing and streaming. Music and phone calls can be streamed directly from compatible devices, including Android and Apple. In addition, SONNET 3 users can stream audio directly from compatible smart TVs and digital media players, free from wires or additional devices..

该设备支持双耳流媒体，双边用户可以将两个SONNET 3处理器或一个SONNET 3和另一个音频处理器与AudioStream配对，以享受最佳的听力和流媒体。音乐和电话可以直接从兼容设备（包括Android和苹果）进行流式传输。此外，十四行诗3用户可以直接从兼容的智能电视和数字媒体播放器流式播放音频，无需使用电线或其他设备。。

SONNET 3 also features a convenient Touch Key for changing programs, a flexible earhook for maximum comfort, and a waterproof IP68 design for water adventures – all while providing users with superior hearing performance.

《十四行诗3》还具有一个方便的触摸键，用于更改程序，一个灵活的耳挂可获得最大的舒适度，以及一个防水IP68设计，用于水上探险，同时为用户提供卓越的听力性能。

“We are thrilled to introduce SONNET 3 to our current cochlear implant users and candidates in the United States. Our smallest and lightest behind-the-ear audio processor with built-in direct streaming is ready to fit seamlessly into everyday life. In addition to comfort and convenience, SONNET 3 offers the superior hearing performance that MED-EL is known for,” said John Sparacio, President and CEO of MED-EL USA..

MED-EL USA总裁兼首席执行官约翰·斯巴拉西奥（JohnSparacio）表示：“我们很高兴向美国目前的人工耳蜗用户和候选人介绍十四行诗3。我们最小、最轻的耳后音频处理器内置直接流媒体，可以无缝地适应日常生活。除了舒适和方便之外，十四行诗3还提供了MED-EL所知的卓越听力表现。”。。

At 2.0g lighter and over 18% shorter than SONNET 2 with AudioStream, SONNET 3 is MED-EL’s smallest behind-the-ear audio processor. The compact design brings users the right combination of comfort and convenience to enjoy sound effortlessly.

十四行诗3比带有AudioStream的十四行诗2轻2.0克，比十四行诗2短18%以上，是MED-EL在ear音频处理器之后最小的。紧凑的设计为用户带来了舒适和便利的正确组合，让他们轻松享受声音。

SONNET 3 is expected to become available in early 2025. However, with MED-EL USA’s TechSwap Program, there is no need to wait for future technology. As of September 1, 2024, patients who receive a MED-EL cochlear implant can exchange one audio processor for the SONNET 3.

。然而，使用MED-EL USA的TechSwap计划，不需要等待未来的技术。截至2024年9月1日，接受MED-EL人工耳蜗植入的患者可以用一个音频处理器交换十四行诗3。

About MED-EL

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by its mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair. Their ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and became the basis for the modern CI today.

MED-EL Medical Electronics是植入式听力解决方案的领导者，其使命是克服听力损失作为沟通和生活质量的障碍。这家总部位于奥地利的私营企业由行业先驱英格伯格（Ingeborg）和埃尔文·霍奇迈尔（ErwinHochmair）共同创立。他们的开创性研究导致了世界上第一个微电子多通道人工耳蜗（CI）的开发，该人工耳蜗于1977年成功植入，并成为当今现代CI的基础。

The company hired its first employees in 1990 and has since grown to more than 2,900 employees across 90 nations and 30 locations worldwide..

。。

The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 137 countries to enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, as well as surgical and non-surgical bone conduction devices.

该公司提供最广泛的植入式和非植入式解决方案来治疗各种类型的听力损失，使137个国家的人们能够在MED-EL设备的帮助下享受听力的礼物。MED-EL的听力解决方案包括耳蜗和中耳植入系统、组合式电声刺激听力植入系统，以及手术和非手术骨传导装置。

.

.

www.medel.com

www.medel.com